CLINICAL_TRIALS
trial_result
· 2022-11-14
Clinical Trial Update: Ipilimumab and Nivolumab in Leptomeningeal Metastases [Phase 2]
Summary
A Phase 2 trial evaluating the combination of ipilimumab and nivolumab for leptomeningeal carcinomatosis has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Leptomeningeal Carcinomatosis | Phase 2 | Status: COMPLETED | Results posted: 2022-11-14